ERBB3 and pancreatic neoplasm: In the present study, we found a decreased viability of the HER3-expressing pancreatic cancer cell line BxPC-3 in the presence of increasing concentrations on the non-toxic control construct ZHER3-ABD-AA (Figure 3), which may have been the result of the cytostatic effect observed earlier.